Cambridge Cognition (COG) Competitors

Cambridge Cognition (LON:COG) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.

Does the media favor COG or RENX?

In the previous week, Renalytix had 2 more articles in the media than Cambridge Cognition. MarketBeat recorded 3 mentions for Renalytix and 1 mentions for Cambridge Cognition. Renalytix's average media sentiment score of 0.28 beat Cambridge Cognition's score of 0.00 indicating that Renalytix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cambridge Cognition	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Renalytix	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in COG or RENX?

Cambridge Cognition received 82 more outperform votes than Renalytix when rated by MarketBeat users. However, 74.19% of users gave Renalytix an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

Company	Underperform	Outperform
Cambridge Cognition	Outperform Votes 105 44.30%	Underperform Votes 132 55.70%
Renalytix	Outperform Votes 23 74.19%	Underperform Votes 8 25.81%

Do insiders & institutionals believe in COG or RENX?

35.2% of Cambridge Cognition shares are held by institutional investors. Comparatively, 28.4% of Renalytix shares are held by institutional investors. 29.9% of Cambridge Cognition shares are held by company insiders. Comparatively, 35.7% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, COG or RENX?

Cambridge Cognition has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500.

Is COG or RENX more profitable?

Renalytix has a net margin of 0.00% compared to Cambridge Cognition's net margin of -10.07%. Cambridge Cognition's return on equity of -74.36% beat Renalytix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-10.07%	-74.36%	-0.30%
Renalytix	N/A	-1,073.18%	-93.54%

Which has higher earnings & valuation, COG or RENX?

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£13.08M	0.89	-£1.32M	-£0.04	-692.50
Renalytix	£2.29M	5.43	-£33.46M	-£0.24	-31.25

Summary

Renalytix beats Cambridge Cognition on 8 of the 15 factors compared between the two stocks.